216 related articles for article (PubMed ID: 27161817)
1. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
[TBL] [Abstract][Full Text] [Related]
2. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Onken JE; Bregman DB; Harrington RA; Morris D; Buerkert J; Hamerski D; Iftikhar H; Mangoo-Karim R; Martin ER; Martinez CO; Newman GE; Qunibi WY; Ross DL; Singh B; Smith MT; Butcher A; Koch TA; Goodnough LT
Nephrol Dial Transplant; 2014 Apr; 29(4):833-42. PubMed ID: 23963731
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
Valério de Azevedo S; Maltez C; Lopes AI
Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
[TBL] [Abstract][Full Text] [Related]
4. Comparative rates of adverse events with different formulations of intravenous iron.
Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Macdougall IC; Strauss WE; McLaughlin J; Li Z; Dellanna F; Hertel J
Clin J Am Soc Nephrol; 2014 Apr; 9(4):705-12. PubMed ID: 24458078
[TBL] [Abstract][Full Text] [Related]
6. Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.
Reed BN; Blair EA; Thudium EM; Waters SB; Sueta CA; Jensen BC; Rodgers JE
Pharmacotherapy; 2015 Jan; 35(1):64-71. PubMed ID: 25556867
[TBL] [Abstract][Full Text] [Related]
7. Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
Ibrahim HN; Foley RN; Zhang R; Gilbertson DT; Collins AJ
Clin J Am Soc Nephrol; 2009 Mar; 4(3):623-9. PubMed ID: 19211669
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
Cançado RD; Brasil SA; Noronha TG; Chiattone CS
Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
[TBL] [Abstract][Full Text] [Related]
9. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
[TBL] [Abstract][Full Text] [Related]
10. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
Gasche C; Dejaco C; Reinisch W; Tillinger W; Waldhoer T; Fueger GF; Lochs H; Gangl A
Digestion; 1999; 60(3):262-7. PubMed ID: 10343140
[TBL] [Abstract][Full Text] [Related]
11. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
Wali A; Mushtaq A; Nilofer
J Pak Med Assoc; 2002 Sep; 52(9):392-5. PubMed ID: 12532571
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Onken JE; Bregman DB; Harrington RA; Morris D; Acs P; Akright B; Barish C; Bhaskar BS; Smith-Nguyen GN; Butcher A; Koch TA; Goodnough LT
Transfusion; 2014 Feb; 54(2):306-15. PubMed ID: 23772856
[TBL] [Abstract][Full Text] [Related]
13. Targeting Iron Deficiency Anemia in Heart Failure.
Saraon T; Katz SD
Prog Cardiovasc Dis; 2016; 58(4):407-15. PubMed ID: 26657161
[TBL] [Abstract][Full Text] [Related]
14. Is there any role of intravenous iron for the treatment of anemia in cancer?
Gemici C; Yetmen O; Yaprak G; Ozden S; Tepetam H; Ozyurt H; Mayadagli A
BMC Cancer; 2016 Aug; 16(1):661. PubMed ID: 27542823
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
Abdel-Razeq H; Abbasi S; Saadi I; Jaber R; Abdelelah H
Drug Des Devel Ther; 2013; 7():939-44. PubMed ID: 24039403
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis].
Ficheux M; Cuny P; Lecouf A; Ryckelynck JP; Hurault de Ligny B; Lobbedez T
Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234
[TBL] [Abstract][Full Text] [Related]
17. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Nash CM; Allen VM
J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
Ambrosy AP; von Haehling S; Kalra PR; Court E; Bhandari S; McDonagh T; Cleland JGF
Am J Cardiol; 2021 Aug; 152():138-145. PubMed ID: 34162484
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]